WebInvestor Relations Financial Reports & SEC Filings Financial Reports. QIAGEN N.V.reports its annual results under U.S. GAAP (SEC filing) due to the listing of our stock at the New York Stock Exchange. As a company established under the laws of The Netherlands we are required by law to also report under IFRS accounting standards. WebApr 11, 2024 · The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 27.40% of the company's stock. Bio-Rad Laboratories Trading Up 0.8 %. Shares of Bio-Rad Laboratories stock opened at $469.95 on Tuesday. Bio-Rad Laboratories, Inc. has a twelve month low of $344.63 and a twelve …
CENTRAL TRUST Co Has $57,000 Position in Bio-Rad Laboratories, …
WebJul 27, 2024 · 10x's Tuesday SEC filing related to the global settlement says the company also agreed to pay Bio-Rad over $29 million in royalties and interest related to sales of GEM products from the date of ... http://bioradlab2024tf.q4web.com/sec-filings/default.aspx how do suppliers influence nhs
BIO-RAD LABORATORIES, INC.: Daskal Ilan (EVP, Chief Financial …
WebApr 11, 2024 · CENTRAL TRUST Co trimmed its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 74.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 135 shares of the medical research company’s stock after … WebAccess Bio-Rad's most recent SEC filings. Please note that Bio-Rad does not maintain or provide information to Q4 Inc. In addition, Bio-Rad makes no representations or … WebLife Science Research. Bio-Rad Products. Genomics; Antibodies; Digital PCR; Flow Cytometry; Transfection; Electrophoresis and Blotting ; Imaging Systems & Software how much should an 85 year old sleep